ESR1 and breast carcinoma: Furthermore, this interaction stopped the accumulation of DNA damage in breast cancer cells and strongly supported the idea that the binding of p53 to ERα–estrogen protects breast cancer cells from apoptosis, hence providing a base for the resistant phenotype.